We are live on ! Find out more
Royce & Associates

Royce & Associates Portfolio holdings

AUM $12.4B Turnover 20.64%
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
Cap. Flow
-$892M
Cap. Flow %
-2.66%
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
NUS icon
Nu Skin
NUS
+$123M
2
DAN icon
Dana Inc
DAN
+$61.6M
3
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
+$55.3M
4
CVEO icon
Civeo
CVEO
+$37.3M
5
PLUS icon
ePlus
PLUS
+$30M

Sector Composition

Rank Sector Weight
1 Industrials 24.45%
2 Technology 18.1%
3 Consumer Discretionary 14.79%
4 Financials 9.92%
5 Materials 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SVM icon
1001
Silvercorp Metals
SVM
$2.16B
$2.56M 0.01%
1,207,300
-15,000
-1% -$28.8K
2013 Q2
4 quarters
INGN icon
1002
Inogen
INGN
$167M
$2.54M 0.01%
+112,755
New +$1.87M
2014 Q2
0 quarters
CACH
1003
DELISTED
CACHE INC (DE)
CACH
$2.54M 0.01%
1,580,100
+67,200
+4% +$149K
2013 Q2
4 quarters
SCU
1004
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$2.51M 0.01%
18,140
+5,800
+47% +$745K
2013 Q2
4 quarters
MCRS
1005
DELISTED
MICROS SYSTEMS INC
MCRS
$2.5M 0.01%
36,740
-34,540
-48% -$1.89M
2013 Q2
4 quarters
GL icon
1006
Globe Life
GL
$12.9B
$2.49M 0.01%
45,600
-5,400
-11% -$289K
2013 Q2
4 quarters
SIG icon
1007
Signet Jewelers
SIG
$4.53B
$2.49M 0.01%
22,520
-79,000
-78% -$8.22M
2013 Q2
4 quarters
KMG
1008
DELISTED
KMG Chemicals Inc
KMG
$2.48M 0.01%
138,100
-1,200
-0.9% -$19.6K
2013 Q2
4 quarters
AMTD icon
1009
DELISTED
TD Ameritrade Holding Corp
AMTD
$2.45M 0.01%
78,200
+12,100
+18% +$375K
2013 Q2
4 quarters
RMD icon
1010
ResMed
RMD
$34.1B
$2.45M 0.01%
48,333
+1,533
+3% +$76K
2013 Q2
4 quarters
GTT
1011
DELISTED
GTT Communications, Inc.
GTT
$2.38M 0.01%
232,660
+25,000
+12% +$261K
2013 Q3
3 quarters
UIS icon
1012
Unisys
UIS
$164M
$2.33M 0.01%
94,000
– –
2013 Q2
4 quarters
UTMD icon
1013
Utah Medical Products
UTMD
$238M
$2.27M 0.01%
44,100
+600
+1% +$30.8K
2013 Q2
4 quarters
PEGA icon
1014
Pegasystems
PEGA
$5.91B
$2.27M 0.01%
214,816
+1,204
+0.6% +$11.5K
2013 Q2
4 quarters
AIXG
1015
DELISTED
Aixtron SE
AIXG
$2.26M 0.01%
155,290
-108,309
-41% -$1.63M
2013 Q2
4 quarters
XTIA icon
1016
XTI Aerospace
XTIA
$30.8M
– –
0
– –
2014 Q2
0 quarters
HDSN icon
1017
Hudson Technologies
HDSN
$212M
$2.25M 0.01%
777,604
– –
2013 Q2
4 quarters
AAN.A icon
1018
DELISTED
The Aaron's Company Inc Class A
AAN.A
$2.23M 0.01%
62,500
+5,300
+9% +$189K
2013 Q2
4 quarters
CAMP icon
1019
DELISTED
CalAmp Corp.
CAMP
$2.22M 0.01%
4,448
+4,348
+4,348% +$2.04M
2013 Q2
4 quarters
CTCM
1020
DELISTED
CTC MEDIA INC COM STK
CTCM
$2.21M 0.01%
200,799
+20,699
+11% +$203K
2013 Q2
4 quarters
DOX icon
1021
Amdocs
DOX
$6.34B
$2.2M 0.01%
47,500
-11,800
-20% -$556K
2013 Q2
4 quarters
AAP icon
1022
Advance Auto Parts
AAP
$2.65B
$2.2M 0.01%
16,301
+1,700
+12% +$211K
2013 Q2
4 quarters
INPH
1023
DELISTED
INTERPHASE CORP
INPH
$2.2M 0.01%
507,729
+4,500
+0.9% +$25.3K
2013 Q2
4 quarters
OFIX icon
1024
Orthofix Medical
OFIX
$391M
$2.15M 0.01%
59,300
-700
-1% -$22.6K
2014 Q1
1 quarter
WTM icon
1025
White Mountains Insurance
WTM
$5.12B
$2.15M 0.01%
3,534
– –
2013 Q2
4 quarters

Similar funds

Royce & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
  • Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
  • Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
  • Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
  • Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
  • Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.

Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.